ArticleRSC advances2021
Correction: Investigation of plasma metabolomics and neurotransmitter dysfunction in the process of Alzheimer's disease rat induced by amyloid beta 25-35.
Mengying Wei, Yuanyuan Liu, Zifeng Pi, Kexin Yue, Shizhe Li, Mingxin Hu, Zhiqiang Liu, Fengrui Song, Zhongying Liu
Abstract readPublished Erratum
In one paragraphArticle in RSC advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
9 authors.
Mengying WeiSchool of Pharmaceutical Sciences, Jilin University 1266 Fujin Road Changchun 130021 China liuzy@jlu.edu.cn +86 431 85619704.
Yuanyuan LiuSchool of Pharmaceutical Sciences, Jilin University 1266 Fujin Road Changchun 130021 China liuzy@jlu.edu.cn +86 431 85619704.
Zifeng PiNational Center for Mass Spectrometry in Changchun, Jilin Province Key Laboratory of Chinese Medicine Chemistry and Mass Spectrometry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences Changchun 130022 China.
Kexin YueSchool of Pharmaceutical Sciences, Jilin University 1266 Fujin Road Changchun 130021 China liuzy@jlu.edu.cn +86 431 85619704.
Shizhe LiGuangdong Univ Technol, Inst Biomed & Pharmaceut Sci Guangzhou 510006 Guangdong People's Republic of China.
Mingxin HuSchool of Pharmaceutical Sciences, Jilin University 1266 Fujin Road Changchun 130021 China liuzy@jlu.edu.cn +86 431 85619704.
Zhiqiang LiuNational Center for Mass Spectrometry in Changchun, Jilin Province Key Laboratory of Chinese Medicine Chemistry and Mass Spectrometry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences Changchun 130022 China.
Fengrui SongNational Center for Mass Spectrometry in Changchun, Jilin Province Key Laboratory of Chinese Medicine Chemistry and Mass Spectrometry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences Changchun 130022 China.
Zhongying LiuSchool of Pharmaceutical Sciences, Jilin University 1266 Fujin Road Changchun 130021 China liuzy@jlu.edu.cn +86 431 85619704.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
[This corrects the article DOI: 10.1039/C9RA00302A.].
Identifiers
PMID35426990
PMCPMC8695072
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390